Antiplatelet drug probably leads to lower death or dependence at end of compared with control (moderate certainty).
It is very uncertain whether antiplatelet drug changes death from any cause during compared with control (very low certainty).
It is very uncertain whether antiplatelet drug changes pulmonary embolism during treatment period compared with control (very low certainty).
It is very uncertain whether antiplatelet drug changes recurrent ischaemic/unknown stroke during treatment period compared with control (very low certainty).
It is very uncertain whether antiplatelet drug changes symptomatic intracranial haemorrhage during treatment period compared with control (very low certainty).
It is very uncertain whether antiplatelet drug changes major extracranial haemorrhage during treatment period compared with control (very low certainty).
Antiplatelet drug probably leads to higher complete recovery from stroke (post hoc) compared with control (moderate certainty).